Outset Medical (OM) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

OM Stock Forecast

Outset Medical stock forecast is as follows: an average price target of $11.00 (represents a 1346.61% upside from OM’s last price of $0.76) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.

OM Price Target

The average price target for Outset Medical (OM) is $11.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $34.00 to $3.00. This represents a potential 1346.61% upside from OM's last price of $0.76.

OM Analyst Ratings

Buy

According to 9 Wall Street analysts, Outset Medical's rating consensus is 'Buy'. The analyst rating breakdown for OM stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 3 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Outset Medical Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 08, 2024	Shagun Singh	RBC Capital	$3.00	$3.40	-11.76%	294.53%
Jun 21, 2024	Shagun Singh	RBC Capital	$6.00	$3.58	67.36%	689.06%
Apr 17, 2024	Rick Wise	Stifel Nicolaus	$6.00	$2.27	164.32%	689.06%
Apr 08, 2024	Maria Thibault	BTIG	$6.00	$2.05	192.68%	689.06%
Apr 05, 2024	Kristen Stewart	C.L. King	$6.00	$1.94	209.28%	689.06%
Nov 11, 2022	-	RBC Capital	$23.00	$17.51	31.35%	2924.72%
Aug 03, 2022	-	Goldman Sachs	$34.00	$19.45	74.76%	4371.33%
Jul 18, 2022	-	Stifel Nicolaus	$24.00	$16.91	41.89%	3056.23%
Jun 14, 2022	-	Stifel Nicolaus	$30.00	$20.41	46.99%	3845.29%

Row per page

Go to

The latest Outset Medical stock forecast, released on Aug 08, 2024 by Shagun Singh from RBC Capital, set a price target of $3.00, which represents a -11.76% decrease from the stock price at the time of the forecast ($3.40), and a 294.53% increase from OM last price ($0.76).

Outset Medical Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	5
Avg Price Target	-	-	$5.40
Last Closing Price	$0.76	$0.76	$0.76
Upside/Downside	-100.00%	-100.00%	610.15%

In the current month, the average price target of Outset Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Outset Medical's last price of $0.76. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 08, 2024	Cowen & Co.	Buy	Buy	Hold
Aug 08, 2024	RBC Capital	Outperform	Sector Perform	Downgrade
Jun 21, 2024	RBC Capital	Sector Perform	Outperform	Upgrade
Apr 08, 2024	BTIG	-	Buy	Initialise
Aug 17, 2023	UBS	-	Neutral	Initialise
Aug 17, 2023	RBC Capital	Outperform	Sector Perform	Initialise
Aug 17, 2023	BMO Capital	-	Outperform	Initialise
Aug 17, 2023	Jefferies	-	Buy	Initialise
Aug 17, 2023	Morgan Stanley	-	Equal-Weight	Initialise
Aug 17, 2023	Piper Sandler	-	Overweight	Initialise

Row per page

Go to

Outset Medical's last stock rating was published by Cowen & Co. on Aug 08, 2024. The company gave OM a "Buy" rating, the same as its previous rate.

Outset Medical Financial Forecast

Outset Medical Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$30.36M	$36.04M	$33.47M	$32.01M	$27.76M	$25.06M	$30.55M	$28.15M	$26.32M	$25.22M	$22.92M	$17.25M	$13.76M
Avg Forecast	$43.11M	$39.48M	$37.56M	$35.25M	$33.24M	$31.88M	$30.36M	$29.54M	$27.87M	$26.84M	$31.17M	$30.35M	$30.50M	$30.39M	$34.79M	$31.75M	$30.92M	$25.22M	$27.50M	$30.11M	$26.43M	$25.13M	$23.73M	$21.45M	$13.76M	$11.53M
High Forecast	$44.58M	$40.83M	$38.84M	$36.45M	$34.38M	$32.97M	$31.40M	$30.62M	$28.00M	$27.82M	$31.17M	$30.35M	$30.62M	$30.40M	$35.98M	$32.83M	$31.98M	$25.22M	$27.50M	$30.11M	$26.43M	$25.13M	$23.73M	$21.45M	$13.76M	$11.53M
Low Forecast	$41.98M	$38.45M	$36.58M	$34.33M	$32.37M	$31.05M	$29.57M	$28.57M	$27.70M	$25.86M	$31.17M	$30.35M	$30.40M	$30.35M	$33.88M	$30.92M	$30.11M	$25.22M	$27.50M	$30.11M	$26.43M	$25.13M	$23.73M	$21.45M	$13.76M	$11.53M
# Analysts	2	2	2	2	1	1	1	4	5	4	1	1	3	6	3	3	4	4	4	4	3	3	3	3	3	3
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00%	1.04%	1.05%	1.04%	1.10%	0.91%	1.01%	1.07%	1.05%	1.06%	1.07%	1.25%	1.19%

Outset Medical's average Quarter revenue forecast for Dec 23 based on 3 analysts is $30.50M, with a low forecast of $30.40M, and a high forecast of $30.62M. OM's average Quarter revenue forecast represents a 0.45% increase compared to the company's last Quarter revenue of $30.36M (Sep 23).

Outset Medical EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	2	2	2	2	1	1	1	4	5	4	1	1	3	6	3	3	4	4	4	4	3	3	3	3	3	3
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-45.45M	$-43.48M	$-40.84M	$-37.92M	$-40.19M	$-43.26M	$-35.09M	$-40.68M	$-28.73M	$-28.43M	$-28.32M	$-29.68M	$-41.43M
Avg Forecast	$-43.11M	$-39.48M	$-37.56M	$-35.25M	$-33.24M	$-31.88M	$-30.36M	$-29.54M	$-27.87M	$-26.84M	$-31.17M	$-38.92M	$-30.50M	$-30.39M	$-34.79M	$-35.39M	$-42.59M	$-25.22M	$-27.50M	$-32.17M	$-26.43M	$-25.13M	$-23.73M	$-31.86M	$-13.76M	$-38.62M
High Forecast	$-41.98M	$-38.45M	$-36.58M	$-34.33M	$-32.37M	$-31.05M	$-29.57M	$-28.57M	$-27.70M	$-25.86M	$-31.17M	$-31.14M	$-30.40M	$-30.35M	$-33.88M	$-28.31M	$-34.07M	$-25.22M	$-27.50M	$-25.73M	$-26.43M	$-25.13M	$-23.73M	$-25.49M	$-13.76M	$-30.90M
Low Forecast	$-44.58M	$-40.83M	$-38.84M	$-36.45M	$-34.38M	$-32.97M	$-31.40M	$-30.62M	$-28.00M	$-27.82M	$-31.17M	$-46.71M	$-30.62M	$-30.40M	$-35.98M	$-42.46M	$-51.10M	$-25.22M	$-27.50M	$-38.60M	$-26.43M	$-25.13M	$-23.73M	$-38.23M	$-13.76M	$-46.35M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.50%	1.25%	1.15%	0.89%	1.59%	1.57%	1.09%	1.54%	1.14%	1.20%	0.89%	2.16%	1.07%

undefined analysts predict OM's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Outset Medical's previous annual EBITDA (undefined) of $NaN.

Outset Medical Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	2	2	2	2	1	1	1	4	5	4	1	1	3	6	3	3	4	4	4	4	3	3	3	3	3	3
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-46.18M	$-44.05M	$-43.97M	$-41.44M	$-40.78M	$-43.84M	$-36.89M	$-41.23M	$-30.47M	$-30.21M	$-30.02M	$-32.04M	$-42.29M
Avg Forecast	$-12.65M	$-13.84M	$-15.03M	$-15.94M	$-17.42M	$-17.59M	$-18.32M	$-18.61M	$-21.27M	$-22.22M	$-22.54M	$-40.92M	$-32.32M	$-35.50M	$-38.13M	$-37.20M	$-43.17M	$-38.70M	$-33.00M	$-33.82M	$-36.83M	$-36.98M	$-35.62M	$-33.78M	$-34.45M	$-39.43M
High Forecast	$-12.22M	$-13.37M	$-14.52M	$-15.40M	$-16.83M	$-16.99M	$-17.70M	$-16.42M	$-20.24M	$-21.46M	$-21.77M	$-32.74M	$-29.14M	$-30.20M	$-36.83M	$-29.76M	$-34.54M	$-38.70M	$-33.00M	$-27.05M	$-36.83M	$-36.98M	$-35.62M	$-27.02M	$-34.45M	$-31.54M
Low Forecast	$-13.21M	$-14.46M	$-15.70M	$-16.65M	$-18.20M	$-18.37M	$-19.14M	$-19.71M	$-21.79M	$-23.21M	$-23.54M	$-49.10M	$-34.97M	$-38.14M	$-39.82M	$-44.64M	$-51.80M	$-38.70M	$-33.00M	$-40.58M	$-36.83M	$-36.98M	$-35.62M	$-40.53M	$-34.45M	$-47.31M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.30%	1.16%	1.18%	0.96%	1.05%	1.33%	1.09%	1.12%	0.82%	0.85%	0.89%	0.93%	1.07%

Outset Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OM's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Outset Medical SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	2	2	2	2	1	1	1	4	5	4	1	1	3	6	3	3	4	4	4	4	3	3	3	3	3	3
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$36.53M	$36.27M	$36.12M	$33.65M	$32.28M	$33.98M	$30.09M	$32.71M	$23.36M	$22.93M	$22.39M	$24.25M	$26.43M
Avg Forecast	$57.33M	$52.50M	$49.94M	$46.87M	$44.20M	$42.39M	$40.37M	$39.28M	$37.06M	$35.69M	$41.45M	$40.36M	$40.56M	$40.41M	$46.27M	$30.34M	$41.11M	$33.54M	$36.56M	$27.58M	$35.14M	$33.41M	$31.55M	$28.52M	$18.30M	$15.34M
High Forecast	$59.28M	$54.29M	$51.65M	$48.47M	$45.71M	$43.84M	$41.75M	$40.71M	$37.24M	$36.99M	$41.45M	$40.36M	$40.72M	$40.43M	$47.85M	$36.40M	$42.52M	$33.54M	$36.56M	$33.09M	$35.14M	$33.41M	$31.55M	$28.52M	$18.30M	$15.34M
Low Forecast	$55.83M	$51.12M	$48.64M	$45.65M	$43.04M	$41.28M	$39.32M	$38.00M	$36.84M	$34.38M	$41.45M	$40.36M	$40.42M	$40.36M	$45.05M	$24.27M	$40.04M	$33.54M	$36.56M	$22.06M	$35.14M	$33.41M	$31.55M	$28.52M	$18.30M	$15.34M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.90%	0.78%	1.19%	0.82%	0.96%	0.93%	1.09%	0.93%	0.70%	0.73%	0.79%	1.33%	1.72%

Outset Medical's average Quarter SG&A projection for Dec 23 is $40.56M, based on 3 Wall Street analysts, with a range of $40.42M to $40.72M. The forecast indicates a 11.01% rise compared to OM last annual SG&A of $36.53M (Sep 23).

Outset Medical EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	2	2	2	2	1	1	1	4	5	4	1	1	3	6	3	3	4	4	4	4	3	3	3	3	3	3
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.93	$-0.90	$-0.90	$-0.86	$-0.85	$-0.92	$-0.78	$-0.87	$-0.65	$-0.66	$-0.70	$-0.75	$-3.44
Avg Forecast	$-0.25	$-0.27	$-0.30	$-0.32	$-0.34	$-0.35	$-0.36	$-0.37	$-0.42	$-0.44	$-0.45	$-0.55	$-0.64	$-0.70	$-0.76	$-0.73	$-0.79	$-0.75	$-0.64	$-0.68	$-0.71	$-0.71	$-0.69	$-0.80	$-0.66	$-2.27
High Forecast	$-0.24	$-0.26	$-0.29	$-0.30	$-0.33	$-0.34	$-0.35	$-0.33	$-0.40	$-0.43	$-0.43	$-0.53	$-0.58	$-0.60	$-0.73	$-0.71	$-0.76	$-0.75	$-0.64	$-0.68	$-0.71	$-0.71	$-0.69	$-0.80	$-0.66	$-2.27
Low Forecast	$-0.26	$-0.29	$-0.31	$-0.33	$-0.36	$-0.36	$-0.38	$-0.39	$-0.43	$-0.46	$-0.47	$-0.57	$-0.69	$-0.76	$-0.79	$-0.76	$-0.82	$-0.75	$-0.64	$-0.68	$-0.71	$-0.71	$-0.69	$-0.80	$-0.66	$-2.27
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.32%	1.19%	1.23%	1.09%	1.14%	1.45%	1.14%	1.23%	0.91%	0.96%	0.87%	1.13%	1.51%

According to undefined Wall Street analysts, Outset Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OM previous annual EPS of $NaN (undefined).

Outset Medical Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
OM	Outset Medical	$0.76	$11.00	1347.37%	Buy
NVRO	Nevro	$4.36	$32.72	650.46%	Hold
SGHT	Sight Sciences	$3.76	$9.00	139.36%	Hold
LUNG	Pulmonx	$6.42	$11.93	85.83%	Buy
SIBN	SI-BONE	$12.29	$20.00	62.73%	Buy
KIDS	OrthoPediatrics	$26.47	$39.60	49.60%	Buy
NPCE	NeuroPace	$9.00	$12.88	43.11%	Buy
CNMD	CONMED	$71.71	$96.00	33.87%	Buy
NARI	Inari Medical	$49.75	$66.11	32.88%	Buy
INSP	Inspire Medical Systems	$186.19	$239.55	28.66%	Buy
OFIX	Orthofix Medical	$18.68	$24.00	28.48%	-
CVRX	CVRx	$14.77	$16.33	10.56%	Buy
CLPT	ClearPoint Neuro	$11.09	$12.00	8.21%	Buy
SWAV	ShockWave Medical	$334.75	$258.17	-22.88%	Hold

OM Forecast FAQ

Is Outset Medical a good buy?

Yes, according to 9 Wall Street analysts, Outset Medical (OM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 66.67% of OM's total ratings.

What is OM's price target?

Outset Medical (OM) average price target is $11 with a range of $3 to $34, implying a 1346.61% from its last price of $0.76. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Outset Medical stock go up soon?

According to Wall Street analysts' prediction for OM stock, the company can go up by 1346.61% (from the last price of $0.76 to the average price target of $11), up by 4371.33% based on the highest stock price target, and up by 294.53% based on the lowest stock price target.

Can Outset Medical stock reach $1?

OM's average twelve months analyst stock price target of $11 supports the claim that Outset Medical can reach $1 in the near future.

What are Outset Medical's analysts' financial forecasts?

Outset Medical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $125.02M (high $129.36M, low $121.56M), average EBITDA is $-125M (high $-122M, low $-129M), average net income is $-71.952M (high $-67.948M, low $-75.415M), average SG&A $166.25M (high $172.01M, low $161.64M), and average EPS is $-1.425 (high $-1.345, low $-1.493). OM's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $155.4M (high $160.71M, low $151.33M), average EBITDA is $-155M (high $-151M, low $-161M), average net income is $-57.465M (high $-55.51M, low $-60.017M), average SG&A $206.64M (high $213.69M, low $201.23M), and average EPS is $-1.138 (high $-1.099, low $-1.188).

Did the OM's actual financial results beat the analysts' financial forecasts?

Based on Outset Medical's last annual report (Dec 2022), the company's revenue was $115.38M, beating the average analysts forecast of $113.74M by 1.43%. Apple's EBITDA was $-158M, beating the average prediction of $-127M by 23.73%. The company's net income was $-163M, beating the average estimation of $-149M by 9.60%. Apple's SG&A was $130M, missing the average forecast of $138.79M by -6.34%. Lastly, the company's EPS was $-3.38, beating the average prediction of $-2.852 by 18.51%. In terms of the last quarterly report (Sep 2023), Outset Medical's revenue was $30.36M, missing the average analysts' forecast of $30.39M by -0.10%. The company's EBITDA was $-45.454M, beating the average prediction of $-30.391M by 49.56%. Outset Medical's net income was $-46.18M, beating the average estimation of $-35.495M by 30.10%. The company's SG&A was $36.54M, missing the average forecast of $40.41M by -9.59%. Lastly, the company's EPS was $-0.93, beating the average prediction of $-0.703 by 32.32%